In recent years, considerable progress has been made in elucidating the molecular pathogenesis of diffuse large B-cell lymphoma (DLBCL) as a clonal malignant expansion of B-cells that are trapped at distinct stages of B-cell differentiation. The development of high-resolution technologies allowing ...
Diffuse large B-cell lymphoma, or DLBCL, is a cancer that starts in white blood cells called lymphocytes. It usually grows in lymph nodes -- the pea-sized glands in your neck, groin, armpits, and elsewhere that are part of your immune system. It can also show up in other areas of yo...
弥漫性大B细胞淋巴瘤 1. Prognosis of R-CHOP regimen in treatment of young adult patients with diffuse large B-cell lymphoma; R-CHOP方案治疗年轻弥漫性大B细胞淋巴瘤患者预后分析 2. Progress in the diagnosis and treatment of diffuse large B-cell lymphoma; 弥漫性大B细胞淋巴瘤诊治进展 更多例句...
Treatment recommendations for patients with diffuse large B-cell lymphoma (DLBCL) begin with evaluating the extent of the disease, performance status of the patient, and histologic subtypes. Treatment of localized and advanced disease varies considerably. Below is a general treatment algorithm for DLBCL...
Newer, more effective and non-cytotoxic therapies are an unmet need for patients with diffuse large B-cell lymphoma (DLBCL) and other B-cell malignancies. Recently approved agents include polatuzumab with bendamustine and rituximab, selinexor, and tafasitamab plus lenalidomide. Three CAR-T cell pr...
Guidelines on diffuse large B-cell lymphoma (DLBCL) have been published by the National Comprehensive Cancer Network (NCCN) [73] and the European Society for Medical Oncology (ESMO). [75] Diagnosis In addition to its general guidance on diagnosis of lymphoma, the NCCN recommends the following...
上海冠导生物工程有限公司生产的HBL-1 [Human diffuse large B-cell lymphoma]人弥漫大B淋巴瘤复苏细胞(附STR鉴定报告),最新报价:1239元/细胞数,
EP: 11.Sequencing Novel Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma EP: 12.Bridging Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Now Viewing EP: 13.Diffuse Large B-Cell Lymphoma: Moving Novel Therapy to the Frontline Setting EP: 14.Management of Diffuse Lar...
1)diffuse large B-cell lymphoma弥漫大B细胞型淋巴瘤 1.Objective To evaluate the efficacy and toxicity of combination of Rituximab and CHOP regimen in diffuse large B-cell lymphoma(DLBCL).目的研究利妥昔单抗联合CHOP方案治疗弥漫大B细胞型淋巴瘤的疗效和不良反应。 2.Objective To observe the effect and...
‘diffuse large B-cell lymphoma’ (DLBCL)large-cell lymphomassmaller T lymphocytesEBV-encoded RNA (EBER)anaplastic tumourshistiocytic sarcomaKikuchi necrotising lymphadenitisborderline subtype, CHLdoi:10.1002/9781119971771.ch14R.N. MirandaJohn Wiley & Sons, Ltd...